NASHVILLE, Tenn.--(BUSINESS WIRE)--

TailorCare, a leader in personalized musculoskeletal (MSK) care navigation and management, today announced the purchase of the advanced computer vision-enabled patient monitoring platform developed by Stabl, a leading healthcare software company.

Stabl’s proprietary technology enables real-time form-tracking to help patients perform exercises safely and effectively from the comfort of their homes without the need for wearable sensors. This technology is especially valuable for patients in between clinical visits or engaging in recovery independently, providing personalized feedback and intelligent engagement opportunities that ensure the patient is on the right path to recovery.

“This addition to our self-care offering builds upon our acquisition of RecoveryOne, and represents a major step forward in our journey to build an industry-leading, integrated platform to support patients navigating and managing their MSK conditions,” said Rachel Winokur, founder and CEO of TailorCare.

Enhancing TailorCare’s Digital MSK Ecosystem

Combining Stabl’s advanced computer vision with TailorCare’s self-care assets—including more than 225 self-care pathways and 1,600 exercises—will enhance TailorCare’s ability to create personalized and engaging experiences, improving access, adherence, and outcomes for individuals managing MSK conditions.

“We’re designing the future of MSK care around the patient,” said John Petito, Chief Strategy Officer at TailorCare. “That means investing in technologies that not only drive better outcomes, but also make the experience safer, simpler, and more personalized—wherever recovery happens.”

About TailorCare

TailorCare is a leading provider of specialty value-based care solutions focused on improving patient outcomes for joint, back, and muscle conditions. We take a deeply personal, data-driven approach by carefully assessing patients’ symptoms, health history, preferences, and goals for musculoskeletal health improvement. Utilizing predictive data and the latest evidence-based guidelines, we guide patients in choosing and navigating the most effective treatment pathways every step of the way. Learn more at www.tailorcare.com and follow us on LinkedIn at @TailorCare.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250910510382/en/

Source: TailorCare